現(xiàn)任北京大學(xué)腫瘤醫(yī)院檢驗(yàn)科主任，兼分子診斷中心副主任，中華醫(yī)學(xué)會(huì)檢驗(yàn)分會(huì)委員，北京醫(yī)學(xué)會(huì)檢驗(yàn)分會(huì)常委，全國(guó)臨床醫(yī)學(xué)計(jì)量技術(shù)委員會(huì)(TC136)委員，中華檢驗(yàn)醫(yī)學(xué)雜志副總編輯，臨床檢驗(yàn)雜志編委，醫(yī)學(xué)參考報(bào)檢驗(yàn)醫(yī)學(xué)頻道副主編。

主要從事臨床化學(xué)與免疫學(xué)檢驗(yàn)標(biāo)準(zhǔn)化與一致性研究、腫瘤治療心肌損害診斷及心臟事件預(yù)警研究、 乳腺癌治療對(duì)骨流失影響的研究和外周血腫瘤個(gè)體化治療基因檢測(cè)方法學(xué)建立及其質(zhì)量控制的研究。

發(fā)表論文:

1. Reference intervals for serum creatinine with enzymatic assay and evaluation of four equations to estimate glomerular filtration rate in a healthy Chinese adult population Clin Chim Acta,2011,2011 Sep 18;412(19-20):1793-7.

2. Trueness investigation of routine creatinine assays on nine homogeneous systems in Beijing demonstrates an encouraging outcome that meets clinical requirements. Chin Med J (Engl).,2010,2010 Sep;123(17):2364-9.

3. Application of five frozen human-pooled serum samples assigned by the International Federation of Clinical Chemistry and Laboratory Medicine reference procedure in a traceability investigation of gamma-glutamyltransferase catalytic concentration measurements in China Ann Clin Biochem,2010,2010 May;47(Pt 3):189-94